The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Mef2c  -  myocyte enhancer factor 2C

Mus musculus

Synonyms: 5430401D19Rik, 9930028G15Rik, AV011172, Mef2, Myocyte-specific enhancer factor 2C
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Mef2c

  • A low expression of FAK, SRF and MEF2C in muscles of dy mice may inhibit postnatal muscle hypertrophy by fusing satellite cells with existing fibers [1].
  • A T7 expression system was used to produce in high yield in Escherichia coli an N-terminal fragment of MEF-2C comprising both the MADS box and the MEF domain [2].
 

High impact information on Mef2c

 

Biological context of Mef2c

 

Anatomical context of Mef2c

 

Physical interactions of Mef2c

 

Other interactions of Mef2c

  • Moreover, there are direct interactions among MEF2C, GRIP-1, and CARM1 [15].
  • These findings identify Bop as an essential downstream effector gene of MEF2C in the developing heart, and reveal a transcriptional cascade involved in development of the anterior heart field and its derivatives [16].
  • Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells [17].
  • These defects did not result from abnormal cardiomyocyte commitment or differentiation, but may relate to defective ventricle formation caused by reduced expression of myocyte enhancer factor 2C (MEF2C) and eHAND [18].
  • BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart [16].

References

  1. Marked reduction of focal adhesion kinase, serum response factor and myocyte enhancer factor 2C, but increase in RhoA and myostatin in the hindlimb dy mouse muscles. Sakuma, K., Nakao, R., Inashima, S., Hirata, M., Kubo, T., Yasuhara, M. Acta Neuropathol. (2004) [Pubmed]
  2. High level expression in soluble form, one step purification, and characterization of the DNA binding domain of MEF-2C. Meierhans, D., Allemann, R.K. Protein Expr. Purif. (1997) [Pubmed]
  3. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. Nakagawa, O., Arnold, M., Nakagawa, M., Hamada, H., Shelton, J.M., Kusano, H., Harris, T.M., Childs, G., Campbell, K.P., Richardson, J.A., Nishino, I., Olson, E.N. Genes Dev. (2005) [Pubmed]
  4. Targeted inhibition of Ca2+/calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Chakkalakal, J.V., Michel, S.A., Chin, E.R., Michel, R.N., Jasmin, B.J. Hum. Mol. Genet. (2006) [Pubmed]
  5. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Zhu, B., Gulick, T. Mol. Cell. Biol. (2004) [Pubmed]
  6. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Martin, J.F., Miano, J.M., Hustad, C.M., Copeland, N.G., Jenkins, N.A., Olson, E.N. Mol. Cell. Biol. (1994) [Pubmed]
  7. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Takeuchi, J.K., Mileikovskaia, M., Koshiba-Takeuchi, K., Heidt, A.B., Mori, A.D., Arruda, E.P., Gertsenstein, M., Georges, R., Davidson, L., Mo, R., Hui, C.C., Henkelman, R.M., Nemer, M., Black, B.L., Nagy, A., Bruneau, B.G. Development (2005) [Pubmed]
  8. Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses. Vong, L.H., Ragusa, M.J., Schwarz, J.J. Genesis (2005) [Pubmed]
  9. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Dodou, E., Verzi, M.P., Anderson, J.P., Xu, S.M., Black, B.L. Development (2004) [Pubmed]
  10. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Wang, D.Z., Valdez, M.R., McAnally, J., Richardson, J., Olson, E.N. Development (2001) [Pubmed]
  11. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. De Val, S., Anderson, J.P., Heidt, A.B., Khiem, D., Xu, S.M., Black, B.L. Dev. Biol. (2004) [Pubmed]
  12. Foxh1 is essential for development of the anterior heart field. von Both, I., Silvestri, C., Erdemir, T., Lickert, H., Walls, J.R., Henkelman, R.M., Rossant, J., Harvey, R.P., Attisano, L., Wrana, J.L. Dev. Cell (2004) [Pubmed]
  13. p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Stanton, L.A., Sabari, S., Sampaio, A.V., Underhill, T.M., Beier, F. Biochem. J. (2004) [Pubmed]
  14. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Illi, B., Scopece, A., Nanni, S., Farsetti, A., Morgante, L., Biglioli, P., Capogrossi, M.C., Gaetano, C. Circ. Res. (2005) [Pubmed]
  15. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2. Chen, S.L., Loffler, K.A., Chen, D., Stallcup, M.R., Muscat, G.E. J. Biol. Chem. (2002) [Pubmed]
  16. BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart. Phan, D., Rasmussen, T.L., Nakagawa, O., McAnally, J., Gottlieb, P.D., Tucker, P.W., Richardson, J.A., Bassel-Duby, R., Olson, E.N. Development (2005) [Pubmed]
  17. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. Ridgeway, A.G., Wilton, S., Skerjanc, I.S. J. Biol. Chem. (2000) [Pubmed]
  18. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Compernolle, V., Brusselmans, K., Franco, D., Moorman, A., Dewerchin, M., Collen, D., Carmeliet, P. Cardiovasc. Res. (2003) [Pubmed]
 
WikiGenes - Universities